David Moore to Cost-Benefit Analysis
This is a "connection" page, showing publications David Moore has written about Cost-Benefit Analysis.
Connection Strength
0,052
-
Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis. Lancet Glob Health. 2017 04; 5(4):e439-e447.
Score: 0,031
-
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ. 2011 Nov 09; 343:d6884.
Score: 0,021